Signals of Change: How Biomarkers Are Reshaping Oncology and Healthcare Delivery
Biomarkers are pivotal for confirming diagnoses, predicting disease progression, and tailoring therapeutic modalities. Recent research focuses on the ‘omics’ technologies — genomics, proteomics, metabolomics.
Cancer remains a leading cause of global mortality, requiring advancement in diagnostic and therapeutic strategies. In modern oncology, cancer biomarkers — biological molecules such as proteins, genes, or metabolites that indicate the presence, progression, or behavior of cancer — have become crucial to diagnosis and treatment.
This field is rapidly evolving, driven by cutting-edge platform technologies and innovative ‘multi-omics’ approaches. An editorial published in September 2025 in Cancers provided a useful review, as well as opinions, on recent progress in the development of cancer biomarkers, exploring how emerging innovations are pushing oncology toward a more proactive, personalized, and economically sound approach.
Walid Qoronfleh, Ph.D.
Author summary: Biomarkers reshape oncology diagnosis and treatment.
More News
- 4-alarm fire in North Baltimore has been contained, SKY 11 reports
- Study Finds Around a Quarter of Polymarket Trades Are Fake
- Mega move incoming? Real Madrid plots Erling Haaland-Kylian Mbappe duo to match Barcelona’s Lamine Yamal brilliance, with little help from Vinicius
- Creepy: GOP Senator Admits Tracking Democratic Colleague's Cars
- Netflix surprise releases first five minutes of ‘Stranger Things’ season 5
- $28 million Glenorchy sports centre inches closer as tender released
- Chelsea eyeing free agent deal for Real Madrid star - Get Spanish Football News
- Tracking Trump and Latin America: Migration—Venezuelans Lose Temporary Protected Status
- NTSB Briefing Reveals CVR Data in UPS Jet Crash
- Velvet-Wood uranium mine construction begins